Greater Occipital Nerve and Cervical Region Injection in Patients With Trigeminal Neuralgia
Overview
- Phase
- Not Applicable
- Intervention
- Lidocaine 1% Injectable Solution
- Conditions
- Trigeminal Neuralgia
- Sponsor
- Dr. Lutfi Kirdar Kartal Training and Research Hospital
- Enrollment
- 29
- Locations
- 1
- Primary Endpoint
- Efficacy on pain severity
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
The aim of this study is to investigate the efficacy of greater occipital nerve block and cervical injections with lidocaine
Detailed Description
After being informed about the study and potantiel risks, all patients giving informed consent will undergo randomization in 1:1 ratio to 1% lidocaine or 0.9% saline groups
Investigators
Cem Bölük
Principal Investigator
Dr. Lutfi Kirdar Kartal Training and Research Hospital
Eligibility Criteria
Inclusion Criteria
- •Classical Trigeminal Neuralgia
Exclusion Criteria
- •Secondary Trigeminal Neuralgia
Arms & Interventions
Active
%1 lidocaine injections to greater occipital nerve and cervical region once a week for 4 weeks
Intervention: Lidocaine 1% Injectable Solution
Outcomes
Primary Outcomes
Efficacy on pain severity
Time Frame: 3 months
Efficacy on pain scores. Visual Analogue Scale (VAS). VAS is a ten-point scale where zero refers to no pain and ten refers to maximal pain
Efficacy on pain frequency
Time Frame: 3 months
Pain frequency per day